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ABSTRACT
MicroRNAs (miRNAs) are important regulators of
eukaryotic gene expression in most biological
processes. They act by guiding the RNAi-induced
silencing complex (RISC) to partially complementary
sequences in target mRNAs to suppress gene ex-
pression by a combination of translation inhibition
and mRNA decay. The commonly accepted mech-
anism of miRNA targeting in animals involves an
interaction between the 50-end of the miRNA called
the ‘seed region’ and the 30 untranslated region
(30-UTR) of the mRNA. Many target prediction algo-
rithms are based around such a model, though
increasing evidence demonstrates that targeting
can also be mediated through sites other than the
30-UTR and that seed region base pairing is not
always required. The power and validity of such in
silico data can be therefore hindered by the
simplified rules used to represent targeting inter-
actions. Experimentation is essential to identify
genuine miRNA targets, however many experimen-
tal modalities exist and their limitations need to be
understood. This review summarizes and critiques
the existing experimental techniques for miRNA
target identification.
INTRODUCTION
MicroRNAs (miRNAs) control gene expression post-
transcriptionally by binding to complementary sequences
in target mRNAs, thereby guiding the effector proteins of
RNAi-induced silencing complex (RISC) into close prox-
imity with the mRNA. Complete complementarity
between miRNA:mRNA pairs is rare in mammals, but
as little as a 6bp match with the target mRNA can be
sufﬁcient to suppress gene expression (1–4). With the ex-
ception of a handful of miRNAs reported to increase
expression of a target gene (5,6), miRNAs repress gene
expression by a combination of mRNA degradation and
translation inhibition. They can promote mRNA degrad-
ation by either of two mechanisms: direct Argonaute2-
catalysed endonucleolytic cleavage of the target (7–10),
or deadenylation and exonucleolytic attack, which is the
predominant mechanism for miRNA activity in mammals
(11). Direct cleavage by Argonaute2 only occurs when
there is near perfect complementarity between the
miRNA and target mRNA (12), a situation that occurs
much more frequently in plants (13) than in mammals
(10,14,15). For a detailed review of miRNA mechanisms
of actions see Krol et al. (16).
The mechanism by which miRNA sequence comple-
mentarity conveys functional binding to mRNA targets
has been studied at length, providing rules for miRNA
target prediction algorithms. One commonly accepted
rule is that the 50 region of a miRNA from nucleotides
2 to 8 (known as the ‘seed’ region) has particular import-
ance in targeting, as demonstrated by numerous biochem-
ical and structural ﬁndings (17). The seed region is the
most evolutionarily conserved region of miRNAs (1,18),
it is the region that is most frequently complementary to
target sites in 30 untranslated region (30-UTRs) (19) and in
many instances a seed match alone is sufﬁcient to confer
mRNA recognition (1,2,20,21). Despite the importance of
the seed region, the 30-end of a miRNA also contributes to
effective binding in roughly 2% of all preferentially
conserved sites (22,23). Furthermore, some validated
miRNA target sites do not have a complete seed match
but instead exhibit 11–12 continuous base pairs in the
central region of the miRNA (15). As new experimental
data like this come to hand the accepted modes of miRNA
targeting are expanded, although prediction programs
may not incorporate all these experimentally derived
possibilities. For example the three most commonly used
bioinformatic target prediction tools Targetscan,
miRanda and PicTar search for miRNA targets exclusive-
ly in mRNA 30-UTRs and do not incorporate evidence of
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region (22,24–26). Also, most algorithms do not adjust
predictions for the co-expression of miRNA and target
which is proposed to be an effective way of improving
predictions (27).
The various miRNA target prediction programs, which
use different rules of targeting, produce rather different
lists of predicted targets. Differences can arise from the
source of 30-UTR sequences; Targetscan uses the Ensembl
database to deﬁne 30-UTRs (28), whereas miRanda uses
the University of California Santa Cruz (UCSC) database
(29). This alone manifests in major differences between
prediction outcomes. Nevertheless, if the Targetscan algo-
rithm is applied to the two separate 30-UTR databases
only a 47% overlap of predicted targets is observed.
Similarly if the miRanda algorithm is applied to both
30-UTR databases separately only a 65% overlap is ob-
served (27). With the identiﬁcation of genuine miRNA
targets lacking a complete 6-mer match (15,30–32) and
the further complications of RNA structure and
RNA-binding proteins affecting site accessibility (33,34),
many predictions may not be bona ﬁde targets and many
genuine targets can be missed (35). Accordingly, the false
positive rate of prediction programs has been variously
calculated to be 24–70% (36–40). This underscores the
requirement for experimental data to demonstrate genuine
miRNA targets and miRNA function.
GENE-SPECIFIC EXPERIMENTAL VALIDATION OF
miRNA TARGETS
Gene-speciﬁc experimental validation with the well-
established techniques of qRT–PCR, luciferase reporter
assays and western blot are commonly used to indicate in-
dividual miRNA:mRNA interactions. For a detailed
review of methods for the experimental validation of spe-
ciﬁc miRNA targets refer to Kuhn et al. (41). Generally,
the downstream effects of differential miRNA expression
are observed at the protein level by western blot and at the
mRNA level by qRT–PCR, although these measures will
not distinguish between direct and secondary miRNA
targets. Reporter assays have been employed extensively
to demonstrate a direct link whereby expression of a
luciferase reporter—30-UTR construct will be altered
through manipulation of a regulatory miRNA. Direct
miRNA effects are demonstrated by the loss of regulation
in constructs with mutated miRNA target sites. The dis-
advantages of reporter assays are that they are labour in-
tensive, dependent upon the region chosen for cloning and
can be sensitive to variances in protocol such as the
method of transfection or promoter identity (42–44).
In the speciﬁc circumstance where a miRNA target is
directly cleaved, RNA ligase mediated—50 rapid identiﬁ-
cation of cDNA ends (50 RLM-RACE) may be used to
conﬁrm such targeting. Brieﬂy 50 RLM-RACE is a PCR-
based technique, whereby an RNA adapter is ligated to
the free 50 phosphate of an uncapped mRNA produced
from, among other nucleolytic activities, Argonaute2-
directed mRNA cleavage. The ligation product can be
reverse transcribed using a forward primer directed
against the linker and a gene speciﬁc reverse primer
which is subsequently PCR ampliﬁed, cloned and identi-
ﬁed by sequencing. 50 RLM-RACE has been used to
support direct cleavage of HOXB8 by miR-196 in the
mouse embryo (45), validate parallel analysis of RNA
ends (PARE) results in mammals (10,14,15), and has
been employed extensively to validate products of
RISC-mediated cleavage in plants (46).
EXPERIMENTAL miRNA TARGET SCREENING
TECHNIQUES
Demonstrating individual miRNA:mRNA interactions
misses the capacity for miRNAs to regulate complex
gene networks. Uncovering networks requires large scale
and unbiased methods of miRNA target identiﬁcation. To
date, the majority of large-scale miRNA target identiﬁca-
tion experiments involve differential expression of a single
miRNA followed by downstream gene-expression or
proteomic analysis. Most commonly, differential expres-
sion is attained by exogenous expression of a miRNA,
however inhibition of an endogenous miRNA is also
possible. Over-expression can be achieved by transient
transfection of a synthetic miRNA precursor or by
stable introduction, typically with a lentiviral vector, of
a miRNA expression construct. miRNA inhibition can
be achieved by expressing modiﬁed antisense oligonucleo-
tides able to bind mature miRNAs and block their activity.
There are a variety of miRNA silencing chemistries
including anti-miRs (47,48), antagomiRs (49), miRNA
sponges (50) and TuD (tough decoy) constructs (51).
Caveats of miRNA over-expression
Despite widespread use, miRNA over-expression experi-
ments are subject to a degree of scepticism for their po-
tential to generate false positive results brought about
through the supraphysiological increase in miRNA levels
generally achieved after transient transfection (52).
Although much of the transfected pre-miR may not be
incorporated into RISC complexes to be functionally
active, this may still be considerably greater increase than
the 20–30% range by which many endogenous miRNAs
ﬂuctuate to modulate gene expression (53). Such
exaggerated miRNA over-expression can potentially satur-
ate RISC complexes and displace other endogenous
miRNAs (54) and consequently cause low afﬁnity target
sites to appear functionally important. The use of miRNA
mimics is a common approach to transiently over-express
miRNAs, however it bypasses the natural mechanism of
miRNA biosynthesis, whereby a transcribed pri-miRNA
is processed by Dicer and Drosha to form the
miRNA:miRNA* duplex. Instead mimics are typically
chemically synthesized duplexes that are designed with
the aim of activation of only one miRNA strand. The
passenger strand will not necessarily be equivalent to the
natural miRNA* form, but the potential still exists for this
strand to be incorporated into RISC and mediate
off-target effects. Another consideration is that over-
expression experiments are commonly performed in a
cell environment that is artiﬁcial to the chosen miRNA,
6846 Nucleic Acids Research, 2011,Vol.39, No. 16in which case cell-speciﬁc natural targets may be missed,
while other targets not normally co-expressed with the
miRNA are detected. For example several studies over-
express brain speciﬁc miR-124 in ovarian cancer (HeLa)
cells (24,26,55).
The inherent problems of over-expression may be
avoided by using miRNA silencing to achieve differential
expression of a miRNA within physiological limits.
However, miRNA silencing by antisense oligonucleotides
is limited by being only as speciﬁc as the inhibitor used.
For example, this approach may not be selective enough
to distinguish between members of the same miRNA
family with similar sequences. Additionally, antisense
oligonucleotides may sequester endogenous miRNAs
without aiding their decay. This means that miRNA quan-
titation by qRT–PCR will not measure a decrease in
miRNA levels following miRNA inhibition, making it dif-
ﬁcult to determine the silencing efﬁciency. When miRNA
inhibition and over-expression strategies are compared, as
has been performed with cartilage-speciﬁc miR-140, the
changes in miRNA abundance after inhibition were not
as great as in a separate over-expression model, though
the mRNA targets identiﬁed are theoretically more
biologically relevant (56).
Gene expression analysis
Degradation of target mRNAs following ectopic miRNA
expression is observable on a genome-wide scale by micro-
array analysis. The ﬁrst reported use of this strategy
demonstrated that following the transfection of miR-1
or miR-124 mimics into HeLa cells, more than 100
mRNAs were down-regulated in each case. Supporting
direct targeting of many of these genes, a 30-UTR motif
search revealed the 6nt consensus sequences matching the
seed regions of miR-1 (CAUUCC) and miR-124 (GUGC
CU) were present in 88 and 76% of down-regulated genes,
respectively. When the same experiment was performed
with a miR-124 mimic with a mutated seed region, the
down-regulated genes were not enriched for miR-124
seed matches (26). Since then, similar results have been
observed in multiple cellular contexts with other
miRNAs (22,26,57,58). Technical advances in next-
generation sequencing technology have now enabled the
use of RNA-seq as an alternative to microarray gene ex-
pression analysis, allowing a deeper analysis to provide a
larger list of inferred miRNA targets in comparable
over-expression studies (59).
The limitation of using differential gene expression to
identify miRNA targets is that they are observed amongst
a pool of indirect changes in transcript abundance. This
may assist in describing the predominate genes and
pathways affected by a miRNA but does not distinguish
between direct targets. Seed matches provide one way of
enriching for direct miRNA targets over secondary effects,
and bioinformatic tools for mining miRNA targets across
large-scale gene expression studies have been developed
(60). Nevertheless, identifying direct targets remains prob-
lematic given the modest effect on levels of some target
mRNAs and the fact some miRNA targeting occurs pre-
dominantly at the level of translational repression (26).
Despite this, the use of gene expression analysis to ﬁnd
miRNA targets is endorsed by a recent report in which at
least 84% of miRNA mediated repression was attributable
to decreased mRNA abundance (61).
Immunoprecipitation of RISC components
Biochemical approaches have been developed to aid the
identiﬁcation of direct miRNA targets. miRNA:mRNA
target pairs can be puriﬁed by the immunoprecipitation
of the RISC components, Argonaute (AGO)
(24,25,38,57,62,63) or TNRC6 (63). Target mRNAs
undergoing direct regulation are co-immunoprecipitated
along with RISC and identiﬁed by microarray or deep
sequencing. Argonaute co-immunoprecipitation has been
applied to identify targets of the well studied miRNAs
miR-1 and miR-124 (25,57). In these examples an exogen-
ous, epitope-tagged Argonaute (AGO2 or AGO1) was ex-
pressed in HeLa or HEK-293T cells together with miR-1
or miR-124, then immunoprecipitated using an antibody
against the epitope tag. Precipitates were analysed by
microarray in comparison to a mock sample. Illustrating
the success of the technique, mRNAs co-immunopre-
cipitated with Argonaute from cells with ectopic miRNA
expression were enriched for seed sequences, with 70% of
the miR-1 targets and 75% of the miR-124 targets having
a 6-mer seed sequence. This degree of enrichment was
highly signiﬁcant over what would be expected by
chance (25). Similar Argonaute immunoprecipitation
methods have been performed in different cell contexts,
including using a hemagglutinin (HA)-tagged AGO1 in
Drosophila Melanogaster Schneider SL2 (S2) cells (38)
and co-immunoprecipitation of endogenous AGO from
HEK293 (62), and from mouse cardiac muscle (64).
Unlike global gene expression analysis experiments with
miRNA over-expression, capturing active miRNA:
mRNA target pairs allows identiﬁcation of mRNAs
r e g u l a t e da tb o t ht h el e v e lo fd egradation and translational
repression.
One potential drawback of the Argonaute co-immuno-
precipitation approach is that it may not necessarily reﬂect
in vivo interactions between molecules if interactions
between RNA and RNA-binding proteins occur subse-
quent to cell lysis (65). This would artiﬁcially facilitate
interactions between RNA and proteins that are usually
segregated by cellular compartments. In addition, this
methodology relies upon a sufﬁciently stable interaction
between the miRNA–mRNA target and the AGO
proteins to survive the co-immunoprecipitation process.
While the above reports were clearly successful in target
enrichment, the potential for loss of targets during this
process is uncertain.
High-throughput sequencing of RNA isolated by
crosslinking immunoprecipitation
To ensure co-immunoprecipitation reﬂects cellular inter-
actions, an advancement on the above-mentioned tech-
nique utilizes ultraviolet irradiation to crosslink RNA to
associated RNA-binding proteins prior to immunopre-
cipitation, followed by deep sequencing to comprehensive-
ly identify bound RNAs (Figure 1). This technique
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isolated by crosslinking immunoprecipitation (HITS-CLIP),
or crosslinking immunoprecipitation (CLIP)-seq] was ﬁrst
applied to mouse brain (24) and subsequently to
Caenorhabditis elegans (66) to identify AGO-bound
miRNA:mRNA complexes. These analyses have provided
compelling data on the location of miRNA binding sites,
within both the 30-UTR and coding sequence, and
generated genome-wide interaction maps for both exogen-
ously expressed miR-124 and general endogenous miRNA
targeting (24). Performing HITS-CLIP on cells with and
without treatment with speciﬁc miRNA antisense inhibi-
tors is likely to provide a powerful method for identiﬁca-
tion of speciﬁc miRNA targets.
HITS-CLIP is a powerful technique capable of
providing an extensive insight to the location of miRNA
targeting within an mRNA. However, it has been criticized
for being limited by the low efﬁciency of UV 254nm RNA–
protein crosslinking (63). Furthermore HITS-CLIP reads
do not precisely pinpoint the position of crosslinking
between the RNA and protein (63), and thus can only
identify a targeted region ( 100-nt) as opposed to a
speciﬁc target site. Many sites identiﬁed by HITS-CLIP
have been validated (24,66), however it is not clear what
percentage of clusters represent genuine target sites.
Photoactivatable-ribonucleoside-enhanced crosslinking and
immunoprecipitation
A modiﬁed crosslinking immunoprecipitation method
for isolating protein-associated RNAs, termed
photoactivatable-ribonucleoside-enhanced crosslinking
and immunoprecipitation (PAR-CLIP) (63), has been de-
veloped to offer more efﬁcient UV crosslinking by
incubating cultured cells with a photoactivatable nucleo-
side such as 4-thiouridine. This improves RNA recovery
by 100- to 1000-fold compared to the HITS-CLIP meth-
odology previously described and also is capable of iden-
tifying the location of the crosslink and thus more
precisely indicate the site of targeting. This is achieved
because the 4-thiouridine that incorporates into RNA
during co-incubation in cell culture results in thymidine
(T) to cytidine (C) transitions more frequently in
cross-linked than non-cross-linked sites, thereby marking
sites of direct interaction (63).
In one study by Hafner et al. (63), PAR-CLIP was per-
formed using epitope tagged Argonaute family members
(AGO 1–4) expressed in HEK293T cells. The most signiﬁ-
cantly enriched 7-mer motifs identiﬁed in co-immuno-
precipitated RNA corresponded to the seed sequences of
the most abundant miRNAs which were generally pos-
itioned 1–2nt downstream of the predominant cross-
linking site. This places the site of crosslinking near the
centre of the AGO–miRNA–mRNA complex and illus-
trates the capacity for using T–C transitions in sequenced
DNA to more speciﬁcally hone in on miRNA:mRNA
interaction sites. Comparable to HITS-CLIP data from
the Darnell lab (24), 46% of miRNA binding sites were
mapped to 30-UTRs, 50% to the mRNA coding region
and 4% to 50-UTRs. Target sites were validated by inhibit-
ing the 25 most highly expressed miRNAs using 20-O-
methyl-modiﬁed antisense oligoribonucleotides followed
by microarray gene expression analysis. mRNAs with
miRNA binding sites were more likely to be up-regulated
after miRNA silencing, with up-regulation being most
frequent when these sites were located within 30-UTRs.
PAR-CLIP of the TNRC6 family, another RISC com-
ponent (63), gave reads of which >50% were within 25nt
of Argonaute crosslinked sites, demonstrating mRNA
targets are in sufﬁciently close proximity to both RISC
components to undergo UV crosslinking. PAR-CLIP of
Argonaute was more efﬁcient than TNRC6, yielding 4000
clusters compared to 600.
Biotin tagged miRNA
In another biochemical approach to enrich for miRNA
targets, Orom and Lund (67) transfected cells with
biotinylated miRNA duplexes and captured miRNA:
mRNA complexes from cell lysates using streptavidin
beads. This technique has been applied in both
Drosophila and mammalian cell lines to independently
demonstrate previously-deﬁned targets of the miRNAs
bantam and miR-124a. In the case of miR-124a, the tech-
nique enriched the known target LAMC1 roughly 5-fold
compared to a control miRNA, and >100-fold compared
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the immunoprecpipitation of biotin tagged miR-10a from
mouse E14 embryonic stem cells showed a signiﬁcant en-
richment of mRNAs encoding ribosomal proteins. It was
further reported that miR-10a targets ribosomal mRNAs
within their 50-UTR to increase translation (68). A poten-
tial advantage of this technique over the immunopre-
cipitation of RISC components is that in principal it can
speciﬁcally pull down targets of a single miRNA, although
the caveats of miRNA over-expression that we discuss
above need be considered. It is not known what affect
the biotin tag has on miRNA binding and the ability of
this technique to comprehensively identify true miRNA
targets has yet to be fully demonstrated.
Detection of direct cleavage targets
Parallel analysis of RNA ends (PARE) identiﬁes mRNA
cleavage products on a global scale by high-throughput
sequencing of products from a modiﬁed 50 RNA ligase
mediated-rapid ampliﬁcation of cDNA ends (50
RLM-RACE) procedure. This takes advantage of the
free 50-monophosphate remaining on the 30 fragment
after Argonaute-mediated cleavage, to which an RNA
adaptor can be ligated without additional chemical modi-
ﬁcation (Figure 2). Subsequent reverse transcription and
PCR ampliﬁcation then enriches these products, prior to
deep sequencing and genomic mapping. PARE, also
known as degradome-seq or genome-wide mapping of
uncapped transcripts (GMUCT) (69,70), has been used
to identify widespread mRNA cleavage events regulated
by miRNAs in Arabidopsis (13,71), rice (72) and limited
cleavages in mammals (10,14,15). Because extensive base
pairing between miRNAs and mRNAs leading to direct
RISC-mediated cleavage does not appear to be a major
mechanism of miRNA activity in mammals, the use of
PARE is most suited to plant systems, where it identiﬁes
the large subset of miRNA targets that are subject to
direct cleavage (73).
Reverse transcription of targets
In a method for detecting miRNA–mRNA complexes de-
veloped by Vatolin and colleagues (74), endogenous
miRNAs are used as primers for cDNA synthesis of
target mRNAs. Because miRNAs bind their mRNA
target within the RISC, a strong detergent is used to dis-
associate these proteins to allow reverse transcriptase to
bind and synthesize cDNA. The cDNA can then be cloned
and sequenced to identify the bound mRNA. This method
has thus far only been applied to C. elegans, where it suc-
cessfully identiﬁed the well established interaction between
the miRNA lin-4 and lin-14 as well as showing a novel
interaction between let-7 and its target K10C3.4 (75).
Proteomic approaches
Stable isotope labelling with amino acids in cell
culture. Stable isotope labelling with amino acids in cell
culture (SILAC) is a high-throughput method for quanti-
tative proteomics in which relative protein abundance is
measured by mass spectrometry of samples labelled with
different isotopes. Because a signiﬁcant degree of miRNA
activity is mediated at the level of translation (40), prote-
omic approaches have an inherent advantage of assaying
the ultimate effect of miRNAs. SILAC has been previous-
ly applied to measure the effect of an over-expressed
miRNA on the proteome by comparing miRNA-
transfected to mock-transfected cells. For example,
SILAC of HeLa cells transfected with miR-1 revealed
the repression of 12 proteins (from a set of 504 detected
proteins) for which there was a signiﬁcant enrichment of
miR-1 seed sequence sites (55). Proteomic investigations
are more limited in their depth of coverage than other
gene expression strategies, but as technologies improve
this should become less problematic. Indeed, subsequent
uses of SILAC have demonstrated that single miRNAs are
capable of repressing the production of hundreds of
proteins (39,40), directly or indirectly. Using SILAC to
identify targets of miR-143, Yang and colleague’s (76)
compared miR-143 mimic- to control-transfected
MiaPaCa2 pancreatic cancer cells. They identiﬁed over
1200 proteins of which 93 were down-regulated more
than 2-fold. Luciferase reporter assays of 34 of these
showed that 10 were likely direct miR-143 targets.
Two-dimensional differentiation in-gel
electrophoresis. Two-dimensional differentiation in-gel
electrophoresis (2D-DIGE) proﬁling is another proteomic
approach that has been applied to the identiﬁcation of
miRNA targets. It involves electrophoresis on a single
gel of two samples labelled with different ﬂuorescent
dyes, separating the proteins by iso-electric focusing and
SDS–PAGE and then identifying them by mass spectrom-
etry. 2D-DIGE has been applied to the investigation of
miR-21 targets in MCF7 cells treated with anti-miR in-
hibitor of miR-21 (77). Mass spectrometry revealed seven
up-regulated proteins, of which three were validated
by western blot, qRT–PCR and reporter assays. In a
separate study of cells transfected with either a miR-29a
mimic or antisense inhibitor, over 100 differentially
regulated proteins were identiﬁed, with ﬂuctuations in
level generally being modest (between 1.2 and 1.7-fold)
(78). Only 14 of these mRNAs contained miR-29a seed
sequences in their 30-UTR, far less than comparable
gene expression analysis experiments (26).
Translation proﬁling
The analysis of mRNAs associated with elongating ribo-
somes identiﬁes translationally active mRNAs. In the tech-
nique of ‘polysome proﬁling’, cyclohexamide is used to
trap elongating ribosomes. Centrifugation through a
sucrose gradient then separates mRNAs with no asso-
ciated ribosomes from those with bound ribosomes which
arepresumably undergoing translation. The polysome pro-
ﬁle of an mRNA provides information on two key par-
ameters of translation; the fraction of the mRNA species
bound by at least one ribosome (referred to as ribosome
occupancy) and the average number of ribosomes bound
per 100 bases of coding sequence (referred to as ribosome
density) (44). Poly(A)
+ RNAs from bound and unbound
pools are isolated, ampliﬁed, coupled to Cy5 and Cy3
dyes, respectively, and competitively hybridized to DNA
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and without over-expression of miR-124 has been used to
determine the relative contribution of translational repres-
sion and mRNA degradation in mediating miRNA
activity (44). Translation proﬁles for  8000 genes were
obtained, revealing around 600 putative miR-124 targets.
In the related method of ‘ribosome proﬁling’ or
‘ribosome footprinting’, cells are lysed after cyclohexamide
treatment then treated with RNAse I to degrade mRNAs
not protected by ribosomes. The resulting 80 S monosomes
are puriﬁed on sucrose gradients and the protected mRNA
fragments identiﬁed by high-throughput sequencing.
Ribosome proﬁling has been applied to HeLa cells trans-
fected with either miR-1, miR-155 or miR-223 (61). By
comparing the effect upon translation determined
through ribosome proﬁling with changes in mRNA level
obtained by microarray analysis, the authors concluded
that at least 84% of miRNA-mediated repression was at-
tributable to mRNA degradation (61). Although transla-
tional proﬁling methods do not directly measure protein
levels they provide quantative data at a greater depth
than currently possible by proteomic approaches, giving a
powerful methodology to determine miRNA activity.
FINDING MULTIPLE miRNAs THAT TARGET A
SINGLE mRNA
While a single miRNA can target many genes, multiple
miRNAs can regulate a single gene (79,80), and methods
to comprehensively identify miRNAs that regulate indi-
vidual genes of interest have been developed. In one
approach individual miRNAs are successively transfected
into a cell line that stably expresses a luciferase reporter
containing the 30-UTR of the target mRNA of interest. In
a study aiming to identify miRNAs targeting p21/Waf,
cells expressing the luciferase-30-UTR reporter gene were
individually transfected with 266 miRNA mimics that had
been bioinformatically predicted to target p21/Waf1 (79).
Of these 266 miRNAs tested, 28 suppressed reporter
activity, including all of the miRNAs previously reported
to target p21/Waf1. Using a similar method, Jiang and
colleagues found that 7 out of 45 miRNAs tested repress
a CyclinD1 30-UTR luciferase reporter (81).
To identify the miRNAs targeting the transcription
factor Hand2, Vo and colleagues (80) used an afﬁnity
puriﬁcation method. The 30-UTR of Hand2 was fused to
an MS2 tag and cloned downstream of a GFP reporter,
which was then transduced into dissociated rat neonatal
cardiomyocytes. Complexes on the chimeric GFP-Hand2-
MS2 mRNA were isolated from cell lysates using an
afﬁnity column containing bound MS2 binding protein,
and the associated miRNAs were identiﬁed using multi-
plex PCR miRNA arrays. One of the identiﬁed miRNAs
was miR-1, which had previously been found to target
Hand2, thereby validating the afﬁnity capture approach.
MiR-133a was also identiﬁed and its targeting of Hand2
was subsequently veriﬁed by mutating miR-133a binding
sites within the Hand2 30-UTR, which abrogated its
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miR-133a was further veriﬁed by its effect on Hand2
mRNA and protein levels and in luciferase reporter
experiments.
These techniques can demonstrate instances where a
single gene is targeted by multiple miRNAs. In contrast
to the reporter assay approach, the afﬁnity puriﬁcation
method has the advantage that it is capable of
demonstrating direct binding, also it does not require fore-
knowledge of potential targeting miRNAs and does not
rely upon miRNA over-expression. A signiﬁcant ﬁnding
was also made possible using the afﬁnity puriﬁcation
protocol that both miR-1 and miR-133a simultaneously
bind to the Hand2 30-UTR and synergistically regulate
Hand2 expression. This was tested by co-transfecting
biotinylated miR-1 with the MS2-tagged Hand2 30-UTR
followed by consecutive afﬁnity puriﬁcation with the MS2
binding protein column and streptavidin beads. miR-1
and miR-133a were both identiﬁed by qRT–PCR (80).
However, both of these techniques are limited to the
region of the mRNA chosen for inclusion in the hybrid
mRNA. Typically this is the 30-UTR, which means
miRNAs targeting the 50-UTR or coding region will not
be identiﬁed.
CONCLUSION
Each individual miRNA is likely to down-regulate the
abundance and/or translation of many mRNAs
(26,39,40,61). Compounding the complexity of miRNA
control, multiple miRNAs can act together on individual
mRNAs to produce additive or synergistic effects on
protein production (79,80). Thus, miRNA research will
increasingly focus upon miRNA-regulated networks
(82), in addition to identifying individual
miRNA:mRNA interactions. Multiple methodologies are
now available to ascertain miRNA targeting, each with
intrinsic strengths and weaknesses as discussed above.
Combining multiple strategies is required to obtain a com-
prehensive high-conﬁdence description of miRNA target-
ing networks.
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